Vishaka Gopalan

发表

A Transcriptionally Distinct Subpopulation of Healthy Acinar Cells Exhibit Features of Pancreatic Progenitors and PDAC

Ashutosh Kumar Singh, E. Ruppin, S. Hannenhalli, 2021, Cancer Research.

miRSCAPE - inferring miRNA expression from scRNA-seq data

S. Hannenhalli, Gulden Olgun, Vishaka Gopalan, 2022, iScience.

Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor

S. Hannenhalli, M. Yohe, C. Thiele, 2022, Cell reports.

Comprehensive single-cell transcriptomic analysis of embryonic melanoblasts uncovers lineage-specific mechanisms of melanoma metastasis and therapy resistance

Maxwell P. Lee, Howard H. Yang, S. Hannenhalli, 2022, bioRxiv.

Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis

S. Hannenhalli, R. Kaplan, J. Drake, 2021, Cell.

Broad misappropriation of developmental splicing profile by cancer in multiple organs

Ashutosh Kumar Singh, S. Hannenhalli, Chi-Ping Day, 2021, bioRxiv.

An Integrated Epigenomic and Transcriptomic Map of Mouse and Human αβ T Cell Development.

S. Hannenhalli, M. Bosticardo, R. Bosselut, 2020, Immunity.

miRSCAPE - Inferring miRNA expression in single-cell clusters

S. Hannenhalli, Gulden Olgun, Vishaka Gopalan, 2021, bioRxiv.

Towards a Synthesis of the Non-Genetic and Genetic Views of Cancer in Understanding Pancreatic Ductal Adenocarcinoma Initiation and Prevention

S. Hannenhalli, Vishaka Gopalan, 2023, Cancers.

Melanoma clonal subline analysis uncovers heterogeneity-driven immunotherapy resistance mechanisms

Howard H. Yang, S. Hannenhalli, C. Sahinalp, 2023, bioRxiv.

Network-based approach elucidates critical genes in BRCA subtypes and chemotherapy response in Triple Negative Breast Cancer

Ashutosh Kumar Singh, S. Hannenhalli, P. Rajagopal, 2023, bioRxiv.

Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response.

S. Hannenhalli, C. Stathopoulos, G. Merlino, 2023, Pharmacology & therapeutics.

Predicting gene expression changes upon epigenomic drug treatment

S. Hannenhalli, P. Agrawal, Vishaka Gopalan, 2023, bioRxiv.

Protocol for using single-cell sequencing to study the heterogeneity of NF1 nerve sheath tumors from clinical biospecimens

S. Hannenhalli, Xiyuan Zhang, J. Shern, 2023, STAR Protocols.

PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models

M. Niepel, B. Telfer, K. Williams, 2023, Nature communications.

Single-cell methylation sequencing data reveal succinct metastatic migration histories and tumor progression models

Erin K. Molloy, Stephen M. Mount, A. Schäffer, 2023, bioRxiv.

Characterizing the role of exosomal miRNAs in metastasis

P. Agrawal, Vishaka Gopalan, Gulden Olgun, 2024, bioRxiv.